Skip to content 
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified. more
| Time Frame | HELX | S&P500 |
|---|---|---|
| 1-Week Return | -3.56% | -1.95% |
| 1-Month Return | -1.79% | 1.21% |
| 3-Month Return | 4.78% | 1.66% |
| 6-Month Return | 20.86% | 8.8% |
| 1-Year Return | 23.16% | 15.51% |
| 3-Year Return | 48.24% | 75.15% |
| 5-Year Return | -18.92% | 70.63% |
| 10-Year Return | 71.62% | 259.71% |
| Stock name | Ticker | Weight |
|---|---|---|
 NATERA INC | NTRA | 10.44% |
 GUARDANT HEALTH INC | GH | 9.43% |
 KRYSTAL BIOTECH INC | KRYS | 5.27% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 4.46% |
 LIGAND PHARMACEUTICALS | LGND | 4.46% |
 TWIST BIOSCIENCE CORP | TWST | 4.11% |
 BRIDGEBIO PHARMA INC | BBIO | 2.96% |
 MEDPACE HOLDINGS INC | MEDP | 2.79% |
 VERTEX PHARMACEUTICALS IN | VRTX | 2.64% |
 UNITED THERAPEUTICS CORP | UTHR | 2.6% |
 ELI LILLY & CO | LLY | 2.52% |
 TRAVERE THERAPEUTICS INC | TVTX | 2.51% |
 VYLOR INC | VYLR | 2.25% |
 REGENERON PHARMACEUTICALS | REGN | 2.15% |
 REPLIGEN CORP | RGEN | 2.06% |
 GRAIL INC | GRAL | 2.03% |
 TEMPUS AI INC-CL A | TEM | 1.96% |
 CAREDX INC | CDNA | 1.79% |
 CHARLES RIVER LABORATORIE | CRL | 1.6% |
 ARGENX SE | 0QW0.IL | 1.41% |
 NEUROCRINE BIOSCIENCES IN | NBIX | 1.41% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 1.27% |
 10X GENOMICS INC-CLASS A | TXG | 1.14% |
 BIONTECH SE-ADR | BNTX | 1.11% |
 IQVIA HOLDINGS INC | IQV | 1.1% |
 PTC THERAPEUTICS INC | PTCT | 1.03% |
 VERACYTE INC | VCYT | 1.01% |
 KINIKSA PHARMACEUTICALS I | KNSA | 1.01% |
 HINGE HEALTH INC-A | HNGE | 0.99% |
 ROYALTY PHARMA PLC- CL A | RPRX | 0.99% |
 THERMO FISHER SCIENTIFIC | TMO | 0.98% |
 STOKE THERAPEUTICS INC | STOK | 0.94% |
 REVOLUTION MEDICINES INC | RVMD | 0.92% |
 PRAXIS PRECISION MEDICINE | PRAX | 0.89% |
 SARTORIUS AG-VORZUG | SRT3.DE | 0.89% |
 CRISPR THERAPEUTICS AG | CRSP | 0.87% |
 INSMED INC | INSM | 0.85% |
 SAMSUNG BIOLOGICS CO LTD | 207940.KS | 0.83% |
 MODERNA INC | MRNA | 0.78% |
 AGILENT TECHNOLOGIES INC | A | 0.72% |
 CADENCE DESIGN SYS INC | CDNS | 0.7% |
 ANAPTYSBIO INC | ANAB | 0.7% |
 ETON PHARMACEUTICALS INC | ETON | 0.64% |
 BEAM THERAPEUTICS INC | BEAM | 0.63% |
 GENMAB A/S -SP ADR | GMAB | 0.61% |
 FIRST TRACKS BIOTHERAPEUT | TRAX | 0.57% |
 QIAGEN N.V. | QIA.DE | 0.53% |
 TG THERAPEUTICS INC | TGTX | 0.51% |
 ASTRAZENECA PLC | AZN.L | 0.51% |
 AXSOME THERAPEUTICS INC | AXSM | 0.51% |
 VERADERMICS INC | MANE | 0.46% |
 GLAUKOS CORP | GKOS | 0.45% |
 ROIVANT SCIENCES LTD | ROIV | 0.44% |
 ARCUTIS BIOTHERAPEUTICS I | ARQT | 0.43% |
 CORTEVA INC | CTVA | 0.4% |
 MINERALYS THERAPEUTICS IN | MLYS | 0.37% |
 COGENT BIOSCIENCES INC | COGT | 0.34% |
 RHYTHM PHARMACEUTICALS IN | RYTM | 0.31% |
 CELCUITY INC | CELC | 0.31% |
 BIO-RAD LABORATORIES-A | BIO | 0.3% |
 BEONE MEDICINES LTD-ADR | ONC | 0.28% |
 TARSUS PHARMACEUTICALS IN | TARS | 0.27% |
 NEUROGENE INC | NGNE | 0.16% |
 GENEDX HOLDINGS CORP | WGS | 0.14% |
 SAMSUNG EPISHOLDINGS CO L | 0126Z0.KS | 0.12% |
 CASH | CASH | 0.1% |
 LIQUIDIA CORP | LQDA | 0.1% |
 SAMSUNG BIO RTS | SAMSUNG.BIO.RTS | 0% |
 OMNIAB INC - 15.00 EARNOU | 2200964 | 0% |
 OMNIAB INC - 12.5 EARNOUT | 2200963 | 0% |
 Net Current Assets | Net.Current.Assets | -0.02% |
| Sector | Weight |
|---|---|
|
Health care | 92.06% |
|
Financials | 2.27% |
|
Information Technology | 0.73% |
|
Materials | 0.42% |
|
All Others | 4.52% |
Franklin Genomic Advancements ETF (HELX) share price today is $41.632.
Yes, Indians can buy shares of Franklin Genomic Advancements ETF (HELX) on Vested. To buy HELX from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Franklin Genomic Advancements ETF (HELX) on Vested. You can start investing in Franklin Genomic Advancements ETF (HELX) with a minimum investment of $1.
The 52-week high price of Franklin Genomic Advancements ETF (HELX) is $45.58. The 52-week low price of Franklin Genomic Advancements ETF (HELX) is $31.24.
The stock symbol (or ticker) of Franklin Genomic Advancements ETF is HELX.
Yes, you can setup SIP in Franklin Genomic Advancements ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of HELX on the Vested app.
The expense ratio of Franklin Genomic Advancements ETF (HELX) is 0.5%.
Link copied 
